Iovance Biotherapeutics, Inc.
Overview
Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing and commercializing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology. The company's therapies are designed to harness a patient's own immune system to eliminate cancer cells.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Iovance Biotherapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Iovance Biotherapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.